CIRCULATING CELL-FREE TUMOR DNA MARKET ANALYSIS

Regional Analysis

Global Circulating Cell-free Tumor DNA Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global Circulating Cell-free Tumor DNA Market over the forecast period. North America holds 45.1% of the market share due to the increasing prevalence of cancer in the region. For instance, according to the American Cancer Society, a scientific cancer journal, in the year 2021, an estimated 1.9 million new cancer cases were diagnosed and 608,570 cancer deaths occurred in the U.S. due to cancer.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa